Merge pull request 'extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion' (#1032) from extract/2025-03-17-norc-pace-market-assessment-for-profit-expansion into main

domains/health/pace-demonstrates-integrated-care-averts-institutionalization-through-community-based-delivery-not-cost-reduction.md

@@ -34,10 +34,16 @@ Some evidence indicates lower mortality rates among PACE enrollees, suggesting q
 
 
 ### Additional Evidence (extend)
-*Source: [[2021-02-00-pmc-japan-ltci-past-present-future]] | Added: 2026-03-15 | Extractor: anthropic/claude-sonnet-4.5*
+*Source: 2021-02-00-pmc-japan-ltci-past-present-future | Added: 2026-03-15 | Extractor: anthropic/claude-sonnet-4.5*
 
 Japan's LTCI provides a national-scale comparison point for PACE's integrated care model. LTCI offers both facility-based and home-based care chosen by beneficiaries, integrating medical care with welfare services across 7 care level tiers. As of 2015, the system served 5+ million beneficiaries (17% of 65+ population) — compared to PACE's 90,000 enrollees in the US. If the US had equivalent coverage, that would represent ~11.4 million people. Japan's experience demonstrates that integrated care delivery can operate at national scale through mandatory insurance, though financial sustainability under extreme aging demographics (28.4% elderly, rising to 40%) remains an ongoing challenge requiring premium and copayment adjustments.
 
+
+### Additional Evidence (confirm)
+*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-16*
+
+2025 data shows PACE serves 80,815 enrollees across 198 programs in 33 states, with most fully integrated capitated model taking 100% responsibility for nursing-home-eligible patients. The report confirms PACE's value proposition is community-based care delivery for complex patients, not cost reduction. However, it adds critical context: nearly half of enrollees are served by just 10 parent organizations, and over half are concentrated in 3 states (CA, NY, PA), indicating the model works but faces severe scaling constraints that prevent national replication.
+
 ---
 
 Relevant Notes:
@@ -46,4 +52,4 @@ Relevant Notes:
 - [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]]
 
 Topics:
-- [[health/_map]]
+- health/_map

domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md

@@ -287,16 +287,22 @@ PACE provides the most comprehensive real-world test of the prevention-first att
 
 
 ### Additional Evidence (extend)
-*Source: [[2024-09-19-commonwealth-fund-mirror-mirror-2024]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
+*Source: 2024-09-19-commonwealth-fund-mirror-mirror-2024 | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
 
 The Commonwealth Fund's 2024 international comparison provides evidence that the prevention-first attractor state is not theoretical — peer nations demonstrate it empirically. The top performers (Australia, Netherlands) achieve better health outcomes with lower spending as percentage of GDP, suggesting their systems have structural features that prevent rather than treat. The US paradox (2nd in care process, last in outcomes, highest spending, lowest efficiency) reveals a system optimized for treating sickness rather than producing health. The efficiency domain rankings (US among worst — highest spending, lowest return) quantify the cost of a sick-care attractor state. The international benchmark shows that systems with better access, equity, and prevention orientation achieve superior outcomes at lower cost, suggesting the prevention-first attractor state is achievable and economically superior to the current US sick-care model.
 
 
 ### Additional Evidence (confirm)
-*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
+*Source: 2025-07-24-kff-medicare-advantage-2025-enrollment-update | Added: 2026-03-15*
 
 C-SNP growth of 71% in one year shows MA plans are rapidly building chronic disease management infrastructure. With 21% of MA enrollment now in SNPs (up from 14% in 2020), the market is structurally shifting toward continuous care management models that align with prevention-first economics.
 
+
+### Additional Evidence (challenge)
+*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-16*
+
+PACE is the strongest counter-evidence to attractor state inevitability. Operating since the 1970s with full capitation for the most complex Medicare/Medicaid patients (avg 76 years, 7+ chronic conditions, nursing-home eligible), PACE has achieved only 0.13% Medicare penetration (80,815 enrollees out of 67M eligible) as of 2025. Seven structural barriers prevent scaling despite clinical success: capital requirements, awareness deficits, insufficient enrollee concentration, geographic concentration in 3 states, dual-eligibility requirements, state-by-state regulatory complexity, and single-state operator structures. The 50-year timeline proves that model superiority does not guarantee market adoption—structural barriers can indefinitely prevent the attractor state even when the model demonstrably works.
+
 ---
 
 Relevant Notes:

domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md

@@ -19,22 +19,28 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
 
 
 ### Additional Evidence (extend)
-*Source: [[2014-00-00-aspe-pace-effect-costs-nursing-home-mortality]] | Added: 2026-03-10 | Extractor: anthropic/claude-sonnet-4.5*
+*Source: 2014-00-00-aspe-pace-effect-costs-nursing-home-mortality | Added: 2026-03-10 | Extractor: anthropic/claude-sonnet-4.5*
 
 PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
 
 
 ### Additional Evidence (extend)
-*Source: [[2024-08-01-jmcp-glp1-persistence-adherence-commercial-populations]] | Added: 2026-03-15 | Extractor: anthropic/claude-sonnet-4.5*
+*Source: 2024-08-01-jmcp-glp1-persistence-adherence-commercial-populations | Added: 2026-03-15 | Extractor: anthropic/claude-sonnet-4.5*
 
 GLP-1 persistence data illustrates why value-based care requires risk alignment: with only 32.3% of non-diabetic obesity patients remaining on GLP-1s at one year (15% at two years), the downstream savings that justify the upfront drug cost never materialize for 85% of patients. Under fee-for-service, the pharmacy benefit pays the cost but doesn't capture the avoided hospitalizations. Under partial risk (upside-only), providers have no incentive to invest in adherence support because they don't bear the cost of discontinuation. Only under full risk (capitation) does the entity paying for the drug also capture the downstream savings—but only if adherence is sustained. This makes GLP-1 economics a test case for whether value-based care can solve the "who pays vs. who benefits" misalignment.
 
 
 ### Additional Evidence (confirm)
-*Source: [[2025-03-01-medicare-prior-authorization-glp1-near-universal]] | Added: 2026-03-15*
+*Source: 2025-03-01-medicare-prior-authorization-glp1-near-universal | Added: 2026-03-15*
 
 Medicare Advantage plans bearing full capitated risk increased GLP-1 prior authorization from <5% to nearly 100% within two years (2023-2025), demonstrating that even full-risk capitation does not automatically align incentives toward prevention when short-term cost pressures dominate. Both BCBS and UnitedHealthcare implemented universal PA despite theoretical alignment under capitation.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-16*
+
+PACE represents the 100% risk endpoint—full capitation for all medical, social, and psychiatric needs, entirely replacing Medicare and Medicaid cards. Yet even at full risk with proven outcomes for the highest-cost patients, PACE serves only 0.13% of Medicare eligibles after 50 years. This suggests the stall point is not just at the payment boundary (partial vs full risk) but at the scaling boundary—capital, awareness, regulatory, and operational barriers prevent even successful full-risk models from achieving market penetration. The gap between 14% bearing full risk and PACE's 0.13% penetration indicates that moving from partial to full risk is necessary but insufficient for VBC transformation.
+
 ---
 
 Relevant Notes:

inbox/archive/.extraction-debug/2025-03-17-norc-pace-market-assessment-for-profit-expansion.json

@@ -0,0 +1,32 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "pace-50-year-failure-to-scale-proves-structural-barriers-prevent-attractor-state-despite-model-success.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "for-profit-pace-entry-signals-potential-scaling-inflection-through-capital-and-operational-capacity.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 2,
+    "kept": 0,
+    "fixed": 2,
+    "rejected": 2,
+    "fixes_applied": [
+      "pace-50-year-failure-to-scale-proves-structural-barriers-prevent-attractor-state-despite-model-success.md:set_created:2026-03-16",
+      "for-profit-pace-entry-signals-potential-scaling-inflection-through-capital-and-operational-capacity.md:set_created:2026-03-16"
+    ],
+    "rejections": [
+      "pace-50-year-failure-to-scale-proves-structural-barriers-prevent-attractor-state-despite-model-success.md:missing_attribution_extractor",
+      "for-profit-pace-entry-signals-potential-scaling-inflection-through-capital-and-operational-capacity.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-16"
+}

inbox/archive/2025-03-17-norc-pace-market-assessment-for-profit-expansion.md

@@ -7,9 +7,13 @@ date: 2025-03-17
 domain: health
 secondary_domains: []
 format: report
-status: unprocessed
+status: enrichment
 priority: high
 tags: [pace, all-inclusive-care, elderly, capitated-care, scaling-barriers, for-profit, integrated-care]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "pace-demonstrates-integrated-care-averts-institutionalization-through-community-based-delivery-not-cost-reduction.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -69,3 +73,12 @@ tags: [pace, all-inclusive-care, elderly, capitated-care, scaling-barriers, for-
 PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
 WHY ARCHIVED: PACE is the strongest counter-evidence and supporting evidence simultaneously — it proves the model works AND that structural barriers prevent scaling. Essential for honest distance measurement.
 EXTRACTION HINT: The 0.13% penetration after 50 years is the key number. Compare to MA's 54% — what does the gap reveal about what actually scales in US healthcare?
+
+
+## Key Facts
+- PACE serves individuals 55+ needing nursing home-level care through government funding
+- PACE average member: 76 years old, 7+ chronic conditions, nursing-home eligible
+- Nearly half of PACE enrollees served by 10 largest parent organizations
+- Only 13 states have 1,000+ PACE enrollees
+- Most PACE parent organizations operate single program in one state
+- PACE eligibility contingent on Medicare + Medicaid dual status